Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck: A prospective phase II trial

Strahlentherapie und Onkologie

Volumn 188, Issue 3, 2012, Pages 235-242

  Vormittag, L ^a   Lemaire, C ^a   Radonjic, D ^a   Kornek, G ^a   Selzer, E ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Capecitabine; Radiotherapy; Recurrence; Squamous cell carcinoma of the head and neck; Treatment outcome

Indexed keywords

CAPECITABINE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER RECURRENCE; CLINICAL ARTICLE; DERMATITIS; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPERSALIVATION; IRRADIATION; MALE; MOUTH SORE; MUCOSA INFLAMMATION; OVERALL SURVIVAL; PAIN; PHASE 2 CLINICAL TRIAL; PNEUMONIA; RADIATION DOSE; TREATMENT RESPONSE; XEROSTOMIA;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUCOSITIS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862691675     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-0040-9     Document Type: Article

References (51)

1. Salama JK, Vokes EE (2008) Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer. Semin Oncol 35:251-261 (Pubitemid 351787700)
2. Wong SJ, Machtay M, Li Y (2006) Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? J Clin Oncol 24:2653-2658 (Pubitemid 46622086)
3. Kao J, Garofalo MC, Milano MT et al (2003) Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev 29:21-30 (Pubitemid 36395520)
4. Salama JK, Vokes EE, Chmura SJ et al (2006) Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 64:382-391 (Pubitemid 43083422)
5. Milano MT, Vokes EE, Salama JK et al (2005) Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy. Int J Radiat Oncol Biol Phys 61:1096-1106 (Pubitemid 40340903)
6. Biagioli MC, Harvey M, Roman E et al (2007) Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 69:1067-1073 (Pubitemid 47625850)
7. Haraf DJ, Weichselbaum RR, Vokes EE (1996) Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease. Ann Oncol 7:913-918 (Pubitemid 26426265)
8. Kasperts N, Slotman B, Leemans CR, Langendijk JA (2005) A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol 41:225-243 (Pubitemid 40326169)
9. Chopra S, Gupta T, Agarwal JP et al (2006) Re-irradiation in the management of isolated neck recurrences: current status and recommendations. Radiother Oncol 81:1-8 (Pubitemid 44540227)
10. Garofalo MC, Haraf DJ (2002) Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer. Curr Opin Oncol 14:330-333 (Pubitemid 34492867)
11. Langendijk JA, Bourhis J (2007) Reirradiation in squamous cell head and neck cancer: recent developments and future directions. Curr Opin Oncol 19:202-209 (Pubitemid 46597478)
12. Nagar YS, Singh S, Datta NR (2004) Chemo-reirradiation in persistent/recurrent head and neck cancers. Jpn J Clin Oncol 34:61-68 (Pubitemid 43115320)
13. Berger B, Belka C, Weinmann M et al (2010) Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol. Strahlenther Onkol 186:255-261
14. Platteaux N, Dirix P, Vanstraelen B, Nuyts S (2011) Outcome after re-irradiation of head and neck cancer patients. Strahlenther Onkol 187(1):23-31
15. Goodwin WJ Jr (2000) Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 110:1-18
16. Parsons JT, Mendenhall WM, Stringer SP et al (1995) Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx. Int J Radiat Oncol Biol Phys 32:605-609
17. Hong WK, Bromer R (1983) Chemotherapy in head and neck cancer. N Engl J Med 308:75-79 (Pubitemid 13221186)
18. Siu LL, Soulieres D, Chen EX et al (2007) Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study. J Clin Oncol 25:2178-2183 (Pubitemid 46954640)
19. Shin DM, Khuri FR, Glisson BS et al (2001) Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma. Cancer 91:1316-1323 (Pubitemid 32267043)
20. Burtness B, Goldwasser MA, Flood W et al (2005) Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol 23:8646-8654 (Pubitemid 46211507)
21. Smith RE, Thornton DE, Allen J (1995) A phase II trial of paclitaxel in squamous cell carcinoma of the head and neck with correlative laboratory studies. Semin Oncol 22:41-46
22. Dreyfuss AI, Clark JR, Norris CM et al (1996) Docetaxel: an active drug for squamous cell carcinoma of the head and neck. J Clin Oncol 14:1672-1678 (Pubitemid 26134226)
23. Forastiere AA, Shank D, Neuberg D et al (1998) Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390). Cancer 82:2270-2274 (Pubitemid 28240836)
24. Hitt R, Jimeno A, Millán JM et al (2004) Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck. Cancer 101:768-775 (Pubitemid 39030933)
25. Chmura SJ, Milano MT, Haraf DJ (2004) Reirradiation of recurrent head and neck cancers with curative intent. Semin Oncol 31:816-821 (Pubitemid 39602688)
26. Spencer SA, Harris J, Wheeler RH et al (2001) RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 51:1299-1304 (Pubitemid 33116324)
27. Cooper JS, Pajak TF, Forastiere AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937-1944
28. Adelstein DJ, Li Y, Adams GL et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92-98
29. Ben-Josef E (2007) Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer. Am J Clin Oncol 30:649-665
30. Czito BG, Willett CG, Bendell JC (2007) Combined-modality therapy for rectal cancer: future prospects. Clin Colorectal Cancer 6:625-633 (Pubitemid 47573867)
31. Dunst J, Debus J, Rudat V et al (2008) Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. Strahlenther Onkol 184:450-456
32. 3NxM0, low rectal cancer: a phase II study. Strahlenther Onkol 187:100-107
33. Miwa M, Ura M, Nishida M et al (1998) Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 34:1274-1281 (Pubitemid 28342121)
34. Sawada N, Ishikawa T, Sekiguchi F et al (1999) X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res 5:2948-2953 (Pubitemid 29493974)
35. Jegannathen A, Mais K, Sykes A et al (2011) Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study. Clin Oncol (R Coll Radiol) 23:149-158
36. Anonymous (1995) LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 31:1049-1091
37. Lee AW, Foo W, Law SC et al (1997) Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement. Int J Radiat Oncol Biol Phys 38:43-52 (Pubitemid 27270941)
38. Ang KK, Jiang GL, Feng Y et al (2001) Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol Biol Phys 50:1013-1020 (Pubitemid 32594840)
39. Lee AW, Foo W, Law SC et al (2000) Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 46:865-872 (Pubitemid 30114398)
40. Grosu AL, Andratschke N, Nieder C, Molls M (2002) Retreatment of the spinal cord with palliative radiotherapy. Int J Radiat Oncol Biol Phys 52:1288-1292 (Pubitemid 34296489)
41. Sminia P, Oldenburger F, Slotman BJ et al (2002) Re-irradiation of the human spinal cord. Strahlenther Onkol 178:453-456 (Pubitemid 34847426)
42. Schultheiss TE (2008) The radiation dose-response of the human spinal cord. Int J Radiat Oncol Biol Phys 71:1455-1459
43. Nieder C, Grosu AL, Andratschke NH, Molls M (2005) Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients. Int J Radiat Oncol Biol Phys 61:851-855 (Pubitemid 40247981)
44. Weichselbaum RR, Beckett MA, Schwartz JL, Dritschilo A (1988) Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int J Radiat Oncol Biol Phys 15:575-579
45. Levendag PC, Meeuwis CA, Visser AG (1992) Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy. Radiother Oncol 23:6-15
46. Teo PM, Kwan WH, Chan AT et al (1998) How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 40:897-913 (Pubitemid 28150809)
47. Morris DE (2000) Clinical experience with retreatment for palliation. Semin Radiat Oncol 10:210-221 (Pubitemid 30452637)
48. Langer CJ, Harris J, Horwitz EM et al (2007) Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol 25:4800-4805 (Pubitemid 350086484)
49. Vermorken JB, Mesia R, Rivera F et al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116-1127
50. Zwicker F, Roeder F, Thieke C et al (2011) IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer. Strahlenther Onkol 187:32-38
51. Balermpas P, Hambek M, Seitz O et al (2009) Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck. Strahlenther Onkol 185:775-781